JDSU Grants Patent Rights for Picosecond Laser to Leading Technology Manufacturer for Development of Microelectronic Products

JDSU (NASDAQ: JDSU) (TSX: JDU) today announced that it has licensed patent rights for fundamental picosecond laser technology to Hamamatsu Corporation for the development of microelectronic products.

Picosecond lasers have become one of the most effective solutions for micromachining due to their accuracy at sending quick and powerful pulses of laser light to an exact point on materials during the creation of very small products. The high precision of the lasers also minimizes heat damage to surrounding areas during the manufacturing process.

In addition to micromachining, picosecond lasers are used for technology applications related to microsurgery, robotics, biological warfare detection, and high-precision optical radar.

"Hamamatsu is excited to leverage key intellectual property from JDSU's extensive patent portfolio in order to provide compelling technology solutions to our customers," said Ken Kaufmann, vice president of Marketing at Hamamatsu Corporation.

"As a technology leader, JDSU continues to grow its intellectual property portfolio with new and compelling solutions. We are pleased to license technology to industry leaders like Hamamatsu," said Chris Castle, product line manager for the CCOP business unit at JDSU.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.